|
A randomized, open-label, phase II study of anti-NaPi2b antibody-drug conjugate (ADC) lifastuzumab (Lifa) vedotin (DNIB0600A) compared to pegylated liposomal doxorubicin (PLD) in patients (pts) with platinum-resistant ovarian cancer (PROC). |
|
|
Travel, Accommodations, Expenses - Clovis Oncology; Genentech |
|
|
|
Consulting or Advisory Role - Amgen; Clovis Oncology; Immunovaccine; Verastem |
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Merck (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
Consulting or Advisory Role - AstraZeneca; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Bayer; Roche |
|
|
|
Consulting or Advisory Role - Clovis Oncology; GamaMabs Pharma; pfizer |
Speakers' Bureau - Pharmamar |
Research Funding - Clovis Oncology (Inst); Genentech (Inst); Pierre Fabre (Inst) |
Travel, Accommodations, Expenses - PharmaMar; Roche |
|
|
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Merrimack |
|
Beata Mackowiak-Matejczyk |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Merck Serono; PharmaMar; Roche/Genentech |
|
|
Employment - GE Healthcare |
Stock and Other Ownership Interests - Genentech |
|
|
Employment - GE Healthcare |
Stock and Other Ownership Interests - Genentech |
|
|
|
Stock and Other Ownership Interests - Genentech |
|
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - Roche/Genentech |
Patents, Royalties, Other Intellectual Property - . |
Travel, Accommodations, Expenses - Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
Employment - GE Healthcare |
Stock and Other Ownership Interests - Genentech |
|
|
|
Stock and Other Ownership Interests - Genentech |
|
|
Employment - GE Healthcare |
Stock and Other Ownership Interests - Genentech |
|
|
Employment - GE Healthcare |
Stock and Other Ownership Interests - Genentech |
|
|
Consulting or Advisory Role - AstraZeneca; Genentech/Roche |
Research Funding - AstraZeneca (Inst); Atara Biotherapeutics (Inst); Boston Biomedical (Inst); Genentech/Roche (Inst); Merrimack (Inst) |